Role of Exocrine and Endocrine Insufficiency in the Management of Patients with Chronic Pancreatitis.
No Thumbnail Available
Identifiers
Date
2020-06-26
Authors
Diéguez-Castillo, Carmelo
Jiménez-Luna, Cristina
Martín-Ruiz, Jose Luis
Martínez-Galán, Joaquina
Prados, José
Torres, Carolina
González-Ramírez, Amanda Rocío
Caba, Octavio
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Exocrine pancreatic insufficiency results from the destruction of the pancreatic parenchyma and is diagnosed by using direct or indirect tests, both of which have shortcomings. Chronic pancreatitis is the most frequent cause of this pathology in adults. Patients meeting radiological or histological diagnostic criteria of chronic pancreatitis are enrolled and the stool elastase test is conducted, considering fecal elastase levels >200 µg/g to represent normal pancreatic function, and levels 200 µg/g to represent normal pancreatic function, and levels Exocrine pancreatic insufficiency is detected in 60% of the patients. Among these, 83.3% are severe cases, and 72% of the latter also are diagnosed with endocrine pancreatic insufficiency (diabetes mellitus). During the nutritional status study, HbA1c levels are significantly higher, and magnesium and prealbumin levels are significantly lower in patients with exocrine pancreatic insufficiency than in those without this disease. Exocrine and endocrine pancreatic insufficiency are highly prevalent among patients with chronic pancreatitis and an early diagnosis of these diseases is vital to improve the clinical management of these patients and reduce their risk of mortality.
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
chronic pancreatitis, diabetes mellitus, exocrine pancreatic insufficiency, nutritional status, pancreatic complications.